# A Study of JNJ-68179280 in Healthy Participants

> **NCT04844463** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 94 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-68179280
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04844463
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-26
- **Primary completion:** 2023-03-07
- **Final completion:** 2023-03-13
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04844463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04844463, "A Study of JNJ-68179280 in Healthy Participants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04844463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*